We found that ATAD2 copy-number, ESR1 expression and E2F1 expression explained 77% of the variation in ATAD2 expression in endometrial cancer, and each of the predictor variables remained significantly associated with ATAD2 expression in the adjusted model (Figure 3a and Table S7). This evidence concerns the gene ESR1 and endometrial cancer.